Innovative Partnership: Flat Medical and Mercury Medical Bring EpiFaith Smart Syringe to US Market

Strategic Alliance Enhancing Anesthesia Safety



In a groundbreaking move for the anesthesia market, Flat Medical has partnered with Mercury Medical to distribute the EpiFaith Smart Syringe across the United States. This innovative syringe revolutionizes traditional epidural procedures by transforming the tactile loss-of-resistance technique into an objective visual signal, significantly improving the accuracy of epidural space identification.

The EpiFaith Smart Syringe allows anesthesia providers to keep both hands free for better needle control, minimizing the risk of accidental dural puncture and its associated complications. This development marks a significant advancement in patient safety during epidural procedures.

Mark Rabe, the Director of Sales and Distribution at Flat Medical, expressed optimism about the partnership, stating, "This collaboration signifies an essential pathway to broaden our services to healthcare professionals throughout America." He noted that Mercury Medical's established sales expertise and comprehensive network will be instrumental in delivering this cutting-edge technology to hospitals nationwide.

With a rich history of over 60 years in clinical equipment, Mercury Medical specializes in airway management and respiratory equipment. The company boasts an extensive distribution network, ensuring that the EpiFaith Smart Syringe reaches various healthcare providers effectively.

John Gargaro, CEO and President of Mercury Medical, shared his enthusiasm about the partnership, commenting, "We are thrilled to combine our strengths with Flat Medical to provide this innovative epidural safety technology to our client base. The EpiFaith Smart Syringe resonates with our commitment to offering advanced, life-saving medical technologies."

The product has not only gained notable industry accolades but also won an Innovative Technology contract from Vizient, Inc. and a Technology Breakthrough Designation from Premier, Inc. It has been adopted globally in various clinical applications, including obstetric anesthesia and interventional pain management, with multiple studies indicating enhanced safety and efficacy compared to traditional techniques.

The collaboration fuses Flat Medical's advanced safety innovations with Mercury Medical's expansive distribution capabilities. This strategic partnership aims to meet the increasing demand for improved epidural procedure safety, significantly benefiting areas such as labor analgesia, surgical anesthesia, and chronic pain management.

About Flat Medical


Founded in 2015, Flat Medical has introduced a range of innovative safety solutions targeting anesthesia, pain management, and critical care. Their flagship products, particularly the EpiFaith syringe, have received widespread acclaim in prominent hospitals globally for enhancing safety standards in clinical practice.

With EpiFaith technology at the forefront of their product line, Flat Medical continues to dedicate itself to improving patient care through cutting-edge medical advancements. This partnership with Mercury Medical not only signifies an important step in their trajectory but also holds promise for better patient outcomes in the US healthcare system.

In conclusion, the launch of the EpiFaith Smart Syringe in partnership with Mercury Medical represents a significant step forward in anesthesia safety. As the healthcare industry increasingly prioritizes patient safety and innovative solutions, collaborations like this pave the way for transformative advancements in medical technology.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.